RegenInnopharm

Seoul, South Korea Founded: 2019 • Age: 7 yrs
It creates innovative technologies of molecular therapeutics for tissue regeneration.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About RegenInnopharm

RegenInnopharm is a company based in Seoul (South Korea) founded in 2019. RegenInnopharm operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.

  • Headquarter Seoul, South Korea
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Not available
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of RegenInnopharm

Premium access

Detailed funding history for RegenInnopharm

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by RegenInnopharm

Investments
Premium access

Investment portfolio details for RegenInnopharm

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - RegenInnopharm

Premium access

Detailed financials for RegenInnopharm

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Regeninnopharm Comparisons

RegenInnopharm Primary company
Description
It creates innovative technologies of molecular therapeutics...
Location
Seoul, South Korea
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for RegenInnopharm

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of RegenInnopharm

RegenInnopharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Novel biopharmaceutical medicines are developed for unmet medical needs.
Locked Locked Locked
Therapies for neurodegenerative and immunology disorders are developed.
Locked Locked Locked
Developer of small molecule therapeutics for endocrine and CNS disorders
Locked Locked Locked
Small molecule drugs for rare diseases are developed.
Locked Locked Locked
Therapies for neurological and neuropsychiatric diseases are developed.
Locked Locked Locked
Genetically engineered cell therapies are developed for multiple disorders.
Premium access

Detailed competitors of RegenInnopharm

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Regeninnopharm

Premium access

Complete news archive for RegenInnopharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RegenInnopharm

RegenInnopharm was founded in 2019.

RegenInnopharm is headquartered in Seoul, South Korea.

RegenInnopharm it creates innovative technologies of molecular therapeutics for tissue regeneration, focusing on various activities. Active on platforms like Facebook, LinkedIn, it serves clients with dedicated solutions emphasizing quality and innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.

RegenInnopharm's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available